FrancophonIA/ELRC3.0 huggingface dataset:
English: The active substance of STAMARIL is a live attenuated yellow fever virus.
Slovenian: Zdravilna učinkovina v zdravilu STAMARIL je živ, oslabljen virus rumene mrzlice.
English: On 11 August 2005, Sanofi Pasteur MSD on behalf of all the Marketing Authorisation Holders (see Annex I) presented to the EMEA a referral under Article 30 of Directive 2001/83/EC, as amended, in order to harmonise the national SPCs of the medicinal product STAMARIL and associated names.
Slovenian: Dne 11. avgusta 2005 je Sanofi Pasteur MSD v imenu vseh imetnikov dovoljenj za promet (glej Dodatek I) na EMEA predložil predlog za postopek v skladu s členom 30 Direktive 2001/83/ES, kot je bila spremenjena, za uskladitev nacionalnih Povzetkov glavnih značilnosti (SPC) zdravila STAMARIL in z njim povezanih imen.
English: London, 4 July 2006 EMEA/169383/2006 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) SUMMARY INFORMATION ON REFERRAL OPINION PURSUANT TO ARTICLE 30 OF COUNCIL DIRECTIVE 2001/83/EC FOR STAMARIL and associated names (See Annex I) International Non-Proprietary Name (INN): Live attenuated yellow fever virus
Slovenian: London, 4.7. 2006 EMEA/169383/2006 ODBOR ZA ZDRAVILA ZA UPORABO V HUMANI MEDICINI (CHMP) POVZETEK MNENJA PO POSTOPKU, IZVEDENEM V SKLADU S ČLENOM 30 DIREKTIVE SVETA 2001/83/ES ZA STAMARIL in z njim povezana imena (Glej Dodatek I) Mednarodno nelastniško ime (INN): Živ, oslabljen virus rumene mrzlice
English: Different Summaries of Product Characteristics (SPC) had been authorised, based on national, divergent decisions from the authorisations in the EU Member States.
Slovenian: Na podlagi nacionalnih, različnih odločitev pristojnih organov v državah članicah EU so bili odobreni različni Povzetki glavnih značilnosti zdravila (SPC).
English: Ref. EMEA/610140/2008
Slovenian: EMEA/610140/2008
English: London, 20 November 2008 Doc.
Slovenian: London, 20. novembra 2008 Sklic dok.
English: In both cases, all medicines were to be started at the same time.
Slovenian: V obeh primerih bi se vsa zdravila uvedla sočasno.
English: In both groups, trastuzumab treatment was continued for a year.
Slovenian: V obeh skupinah je zdravljenje s trastuzumabom trajalo eno leto.
English: The main measure of effectiveness was how long the patients survived until their cancer came back.
Slovenian: Glavno merilo učinkovitosti je bil čas preživetja bolnikov do ponovitve raka.
English: The evaluation had finished and the CHMP had given a negative opinion.
Slovenian: Postopek ocenjevanja je bil zaključen in CHMP je izrazil negativno mnenje.
English: The company had initiated an appeal process, but this had not yet finished when the company withdrew.
Slovenian: Družba je sprožila pritožbeni postopek, vendar se ta še ni zaključil, ko je družba podala zahtevek za umik.
English: International non-proprietary name (INN): docetaxel
Slovenian: Mednarodno nelastniško ime (INN): docetaksel
English: If you are in a clinical trial and need more information about your treatment, contact the doctor who is giving it to you.
Slovenian: Če ste vključeni v klinično preskušanje ter potrebujete več informacij o zdravljenju, se obrnite na zdravnika, ki vam je predpisal zdravljenje.
English: The letters from the company notifying the EMEA of the withdrawal of the application are available here and here.
Slovenian: Dopisa, s katerima družba agencijo EMEA obvešča o umiku vloge, sta na voljo tukaj in tukaj.
English: Docetaxel blocks the ability of cells to destroy the internal ‘skeleton' that allows them to divide and multiply.
Slovenian: Docetaksel blokira sposobnost celic za uničevanje notranjega „skeleta“, ki jim omogoča deljenje in razmnoževanje.
English: What were the main concerns of the CHMP?
Slovenian: Kateri so bili glavni zadržki CHMP?
English: With the skeleton still in place, the cells cannot divide and they eventually die.
Slovenian: Ker skelet ostane nespremenjen, se celice ne morejo deliti in sčasoma odmrejo.
English: The study compared the effectiveness of the following treatment combinations, which were used in addition to surgery:
Slovenian: V študiji so primerjali uèinkovitost naslednjih kombinacij zdravil, ki so se uporabila poleg operativnega posega:
English: Docetaxel affects not only cancer cells, but also non-cancer cells such as blood cells, which can cause side effects.
Slovenian: Docetaksel ne vpliva le na rakave celice, ampak tudi na nerakave celice, kot so krvne celice, kar lahko povzroči neželene učinke.
English: There are no consequences on the use of Taxotere/Docetaxel Winthrop in its authorised indications, for which the balance of benefits and risks remains unchanged.
Slovenian: Umik nima nobenih posledic za uporabo zdravila Taxotere/Docetaxel Winthrop za odobrene indikacije, pri katerih ostaja razmerje med koristmi in tveganji nespremenjeno.
English: It is used in breast cancer that is advanced or ‘metastatic' (has spread to other parts of the body), and in breast cancer that can be treated with surgery.
Slovenian: Uporablja se pri raku dojke, ki je napredoval ali ima zasevke (se je razširil na druge dele telesa), ter pri raku dojke, ki ga je možno zdraviti z operativnim posegom.
English: • together with trastuzumab (another anticancer medicine), following treatment with doxorubicin and cyclophosphamide;
Slovenian: • skupaj s trastuzumabom (drugim zdravilom proti raku) po zdravljenju z doksorubicinom in ciklofosfamidom;
English: • together with trastuzumab and carboplatin (another anticancer medicine).
Slovenian: • skupaj s trastuzumabom in karboplatinom (drugim zdravilom proti raku).
English: The CHMP was also concerned that the company did not provide sufficient clinical evidence to justify the use of the combination of Taxotere/Docetaxel Winthrop, carboplatin and trastuzumab.
Slovenian: Odbor je menil tudi, da družba ni predložila zadostnih kliniènih dokazov za utemeljitev uporabe kombinacije zdravila Taxotere/Docetaxel Winthrop, karboplatina in trastuzumaba.
English: On 14 November 2008, Sanofi-Aventis Pharma S.A. officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a new indication for Taxotere/Docetaxel Winthrop, to add the treatment of patients with operable breast cancer whose tumours overexpress HER2 in combination with trastuzumab, with or without carboplatin.
Slovenian: Družba Sanofi-Aventis Pharma S.A. je dne 14. novembra 2008 uradno obvestila Odbor za zdravila za uporabo v humani medicini (CHMP), da želi umakniti vlogo za novo indikacijo za zdravilo Taxotere/Docetaxel Winthrop, tj. za dodatek zdravljenja bolnic z operabilnim rakom dojke, katerega tumorji imajo čezmerno izražajo HER2, v kombinaciji s trastuzumabom in karboplatinom ali brez njega.
English: The CHMP was concerned that it was not possible to establish the benefits of the treatment combinations including Taxotere/Docetaxel Winthrop when used in addition to surgery, because of the way the single main study was designed.
Slovenian: CHMP je menil, da ni bilo mogoèe ugotoviti koristi kombinacij zdravljenja, vkljuèno z zdravilom Taxotere/Docetaxel Winthrop, kot dodatkov po operativnem posegu zaradi naèina zasnove edine glavne študije.
English: Questions and answers on the withdrawal of the application for a change to the marketing authorisation for Taxotere/Docetaxel Winthrop
Slovenian: Vprašanja in odgovori v zvezi z umikom vloge za spremembo dovoljenja za promet z zdravilom Taxotere/Docetaxel Winthrop
English: Taxotere/Docetaxel Winthrop was also expected to be used to treat breast cancer that can be treated with surgery when the cancer has been shown to be ‘expressing' large amounts of HER2: this is a type of cancer that produces (expresses) a specific protein called HER2 in large quantities on the surface of the tumour cells.
Slovenian: Zdravilo Taxotere/Docetaxel Winthrop naj bi se uporabljalo za zdravljenje raka dojke, ki ga je mogoèe zdraviti z operativnim posegom, èe se ugotovi, da rak „izraža“ velike kolièine HER2: to je vrsta raka, ki na površini rakavih celic v velikih kolièinah tvori (izraža) doloèeno beljakovino, imenovano HER2.
English: It contains the active substance docetaxel.
Slovenian: Vsebuje zdravilno uèinkovino docetaksel.
English: Taxotere/Docetaxel Winthrop is an anticancer medicine.
Slovenian: Taxotere/Docetaxel Winthrop je zdravilo proti raku.
English: Based on the review of the data and the company's response to the CHMP list of questions, at the time of the withdrawal, the CHMP had given a negative opinion and did not recommend a marketing authorisation for Taxotere/Docetaxel Winthrop in the treatment of patients with operable breast cancer whose tumours overexpress HER2 in combination with trastuzumab, with or without carboplatin.
Slovenian: Na podlagi pregleda podatkov in odgovorov družbe na seznam vprašanj, ki jih je do umika vloge zastavil CHMP, je Odbor izrazil negativno mnenje in ni priporočil odobritve dovoljenja za promet z zdravilom Taxotere/Docetaxel Winthrop, namenjenim zdravljenju bolnikov z rakom dojke, ki ga je možno zdraviti z operativnim posegom in katerega tumorji čezmerno izražajo HER2, v kombinaciji s trastuzumabom in s karboplatinom ali brez njega.
English: Taxotere/Docetaxel Winthrop has been studied in one main study involving over 3,000 women with HER2-expressing breast cancer that could be treated with surgery.
Slovenian: Zdravilo Taxotere/Docetaxel Winthrop je bilo prouèeno v eni glavni študiji, v katero je bilo vkljuèenih veè kot 3 000 žensk z rakom dojke, ki je izražal HER2 in ga je bilo možno zdraviti z operativnim posegom.
English: The company informed the CHMP that there are no consequences for patients currently included in clinical trials with Taxotere/Docetaxel Winthrop.
Slovenian: Družba je obvestila CHMP, da umik nima nobenih posledic za bolnike, ki trenutno sodelujejo v kliničnih preskušanjih zdravila Taxotere/Docetaxel Winthrop.
English: What are the consequences of the withdrawal for patients undergoing clinical trials with Taxotere/Docetaxel Winthrop?
Slovenian: Kakšne so posledice umika za bolnike, ki sodelujejo v kliničnih preskušanjih zdravila Taxotere/Docetaxel Winthrop?
English: What is happening for Taxotere/Docetaxel Winthrop for the treatment of other types of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma and head and neck cancer?
Slovenian: Kakšne so posledice za zdravilo Taxotere/Docetaxel Winthrop, indicirano za zdravljenje drugih vrst raka dojke, nedrobnoceličnega pljučnega raka, raka prostate, adenokarcinoma želodca ter raka glave in vratu.
English: In these patients, Taxotere/Docetaxel Winthrop is used in addition to surgery to remove the tumour, together with doxorubicin and cyclophosphamide (other anticancer medicines).
Slovenian: Pri teh bolnicah se zdravilo Taxotere/Docetaxel Winthrop uporablja kot dodatek operativnemu posegu za odstranitev tumorja skupaj z doksorubicinom in ciklofosfamidom (drugi dve zdravili proti raku).
English: Taxotere/Docetaxel Winthrop was expected to be used in addition to surgery to remove the tumour in the following treatment combinations:
Slovenian: Zdravilo Taxotere/Docetaxel Winthrop naj bi se uporabljalo kot dodatek operativnemu posegu za odstranitev tumorja v naslednjih kombinacijah zdravljenja:
English: Taxotere/Docetaxel Winthrop is also used in advanced or metastatic non-small cell lung cancer, in prostate cancer, in metastatic gastric adenocarcinoma (a type of stomach cancer) and in advanced head and neck cancer.
Slovenian: Zdravilo Taxotere/Docetaxel Winthrop se uporablja tudi pri napredovalem ali metastatskem nedrobnoceličnem pljučnem raku , raku prostate, metastatskem adenokarcinomu želodca (vrsta želodčnega raka) in pri napredovalem raku glave in vratu.
English: Therefore, at the time of the withdrawal, the CHMP's view was that a benefit of Taxotere/Docetaxel Winthrop had not been sufficiently demonstrated and any benefits did not outweigh the identified risks.
Slovenian: CHMP je v času umika menil, da koristi zdravila Taxotere/Docetaxel Winthrop niso bile zadostno dokazane in da ne odtehtajo znanih tveganj.
English: Taxotere/Docetaxel Winthrop is a concentrate and solvent, which are made up into a solution for infusion (drip into a vein).
Slovenian: Zdravilo Taxotere/Docetaxel Winthrop je koncentrat in vehikel, ki se uporabljata za pripravo raztopine za infundiranje (vnašanje po kapljicah v veno).
English: The active substance in Taxotere/Docetaxel Winthrop, docetaxel, belongs to the group of anticancer medicines known as the ‘taxanes'.
Slovenian: Zdravilna učinkovina zdravila Taxotere/Docetaxel Winthrop, docetaksel, spada v skupino zdravil proti raku, ki jim pravimo „taksani“.
English: What is Taxotere/Docetaxel Winthrop?
Slovenian: Kaj je zdravilo Taxotere/Docetaxel Winthrop?
English: • the combination of Taxotere/Docetaxel Winthrop, trastuzumab and carboplatin for 18 weeks.
Slovenian: • 18-tedenska kombinacija zdravila Taxotere/Docetaxel Winthrop s trastuzumabom in karboplatinom.
English: How is Taxotere/Docetaxel Winthrop expected to work?
Slovenian: Kako naj bi zdravilo Taxotere/Docetaxel Winthrop delovalo?
English: • the combination of doxorubicin and cyclophosphamide for 12 weeks, followed by
Slovenian: • 12-tedenska kombinacija doksorubicina in ciklofosfamida, čemur je sledila 12-tedenska uporaba zdravila Taxotere/Docetaxel Winthrop s trastuzumabom ali brez njega;
English: What was Taxotere/Docetaxel Winthrop expected to be used for?
Slovenian: Za kaj naj bi se zdravilo Taxotere/Docetaxel Winthrop uporabljalo?
English: Slovak Republic ratiopharm International GmbH
Slovenian: Slovaška ratiopharm International GmbH
English: List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states
Slovenian: Dodatek I Seznam imen, farmacevtskih oblik, jakosti zdravila, poti uporabe zdravila, imetnikov dovoljenja za promet z zdravilom v državah članicah
English: Germany mibe GmbH Arzneimittel Münchener Str. 15
Slovenian: Nemčija mibe GmbH Arzneimittel Münchener Str. 15
English: Czech Republic
Slovenian: Češka
English: Germany ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Slovenian: Nemčija ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
English: Osteodon 200 IU.
Slovenian: Osteodon 200 I.U.
English: United Kingdom
Slovenian: Velika Britanija
English: 200 IU
Slovenian: 200 UI
English: Miacalcic 200 i.e./odmerek pršilo za nos, raztopina
Slovenian: Miacalcic 200 i.e./odmerek pršilo za nos, raztopina pršilo za nos, raztopina nazalna uporaba
English: Miacalcic Nasal 100 100 IU
Slovenian: Miacalcic Nasal 100 100 i.e.
English: 200 IU/dose, 2000 IU/ML
Slovenian: 200 i.e./odmerek, 2000 i.e./ML
English: 400 IU
Slovenian: 400 i.e.
English: Miacalcic Nasal 200 200 IU
Slovenian: Miacalcic Nasal 200 200 i.e.
English: Calcitonina Wander 200 200 IU/dose nebuliser solution nasal use
Slovenian: Calcitonina Wander 200 200 i.e./odmerek inhalacijska raztopina za nebulator nazalna uporaba
English: 2200 i.e./ml
Slovenian: 200 i.e. i.m.
English: TONOCALCIN 200 IU nosová aerodisperzia 200 IU/0,1 ml
Slovenian: TONOCALCIN 200 IU nosová aerodisperzia 200 i.e./0,1 ml pršilo za nos, raztopina nazalna uporaba
English: Calcitonin 'Novartis' 50 I.E./ml - Lösung zur Injektion und Infusion solution for injection/infusion subcutaneous use, intramuscular use, intravenous use
Slovenian: Calcitonin 'Novartis' 50 I.E./ml - Lösung zur Injektion und Infusion raztopina za injiciranje/infundiranje subkutana uporaba, intramuskularna uporaba, intravenska uporaba
English: Miacalcic Solution for Injection 100IU/ml solution for injection subcutaneous, intramuscular and intravenous use
Slovenian: Miacalcic Solution for Injection 100IU/ml raztopina za injiciranje subkutana, intramuskularna in intravenska uporaba
English: ESPECIALIDADES FARMACEUTICAS CENTRUM, S.A Sagitario, 14 03006 Alicante
Slovenian: ESPECIALIDADES FARMACEUTICAS CENTRUM, S.A Sagitario,
English: Calcitonine-Sandoz 100 IE/ml, oplossing voor injectie en infusie solution for injection/infusion subcutaneous use, intramuscular use, intravenous use
Slovenian: Calcitonine-Sandoz 100 IE/ml, oplossing voor injectie en infusie raztopina za injiciranje/infundiranje subkutana uporaba, intramuskularna uporaba, intravenska uporaba
English: Calcitonin 'Novartis' 100 I.E./ml - Lösung zur Injektion und Infusion solution for injection/infusion subcutaneous use, intramuscular use, intravenous use
Slovenian: Calcitonin 'Novartis' 100 I.E./ml - Lösung zur Injektion und Infusion raztopina za injiciranje/infundiranje subkutana uporaba, intramuskularna uporaba, intravenska uporaba
English: 0,25 mg powder and solvent for solution for injection intramuscular use, intravenous use, subcutaneous use
Slovenian: 0,25 mg prašek in vehikel za raztopino za injiciranje intramuskularna uporaba, intravenska uporaba, subkutana uporaba
English: Karil 100 I.E. Injektionslösung solution for injection intravenous use, intramuscular use, subcutaneous use
Slovenian: Karil 100 I.E. Injektionslösung raztopina za injiciranje intravenska uporaba, intramuskularna uporaba, subkutana uporaba
English: TONOCALCIN 100 IU nosová aerodisperzia 100 IU/0,1 ml
Slovenian: TONOCALCIN 100 IU nosová aerodisperzia 100 i.e./0,1 ml pršilo za nos, raztopina nazalna uporaba
English: 0,50 mg powder and solvent for solution for injection intramuscular use, intravenous use, subcutaneous use
Slovenian: 0,50 mg prašek in vehikel za raztopino za injiciranje intramuskularna uporaba, intravenska uporaba, subkutana uporaba
English: Calcitonin 100 I.E.Rotexmedica solution for injection intravenous use, intramuscular use, subcutaneous use
Slovenian: Calcitonin 100 I.E.Rotexmedica raztopina za injiciranje intravenska uporaba, intramuskularna uporaba, subkutana uporaba
English: 100 IU/1ML AMP solution for injection intramuscular use
Slovenian: 100 i.e./1 ml amp raztopina za injiciranje intramuskularna uporaba
English: Calcitonine Sandoz solution for injection intramuscular use, intravenous use, subcutaneous use
Slovenian: Calcitonine Sandoz raztopina za injiciranje intramuskularna uporaba, intravenska uporaba, subkutana uporaba
English: Calcitonin-CT 100 I.E./0,1ml Nasenspray 100 IU / dose
Slovenian: Calcitonin-CT 100 I.E./0,1 ML Nasenspray 100 i.e./odmerek pršilo za nos, raztopina nazalna uporaba
English: Calcitonin 50 I.E.Rotexmedica solution for injection intravenous use, intramuscular use, subcutaneous use
Slovenian: Calcitonin 50 I.E.Rotexmedica raztopina za injiciranje intravenska uporaba, intramuskularna uporaba, subkutana uporaba
English: CALCO 100 NE/ml injekció solution for injection subcutaneous use, intramuscular use, intravenous use
Slovenian: CALCO 100 NE/ml injekció raztopina za injiciranje subkutana uporaba, intramuskularna uporaba, intravenska uporaba
English: 200 IU/dose nasal spray, liquid nasal use
Slovenian: 200 i.e./odmerek pršilo za nos, tekočina nazalna uporaba
English: powder and solvent for solution for injection intramuscular use, subcutaneous use
Slovenian: prašek in vehikel za raztopino za injiciranje intramuskularna uporaba, subkutana uporaba
English: Tonocalcin solution for injection intramuscular use, subcutaneous use
Slovenian: Tonocalcin raztopina za injiciranje intramuskularna uporaba, subkutana uporaba
English: CALCO 50 NE/ml injekció solution for injection subcutaneous use, intramuscular use, intravenous use
Slovenian: CALCO 50 NE/ml injekció raztopina za injiciranje subkutana uporaba, intramuskularna uporaba, intravenska uporaba
English: Calcitonin Stada 50 I.E. Injektionslösung solution for injection intravenous use, intramuscular use, subcutaneous use
Slovenian: Calcitonin Stada 50 I.E. Injektionslösung raztopina za injiciranje intravenska uporaba, intramuskularna uporaba, subkutana uporaba
English: Calcitonin-ratiopharm 100 I.E. Ampullen solution for injection intravenous use, intramuscular use, subcutaneous use
Slovenian: Calcitonin-ratiopharm 100 I.E. Ampullen raztopina za injiciranje intravenska uporaba, intramuskularna uporaba, subkutana uporaba
English: Calcitonine Pharmy II 50 IU/ml solution for injection intramuscular use, intravenous use, subcutaneous use
Slovenian: Calcitonine Pharmy II 50 i.e./ml raztopina za injiciranje intramuskularna uporaba, intravenska uporaba, subkutana uporaba
English: Calcitonine Pharmy II 100 IU/ml solution for injection intramuscular use, intravenous use, subcutaneous use
Slovenian: Calcitonine Pharmy II 100 i.e./ml raztopina za injiciranje intramuskularna uporaba, intravenska uporaba, subkutana uporaba
English: MIACALCIC 50 NE/ml oldatos injekció és infúzió solution for injection/infusion subcutaneous use, intramuscular use, intravenous use
Slovenian: MIACALCIC 50 NE/ml oldatos injekció és infúzió raztopina za injiciranje/infundiranje subkutana uporaba, intramuskularna uporaba, intravenska uporaba
English: MIACALCIC 100 NE/ml oldatos injekció és infúzió solution for injection/infusion subcutaneous use, intramuscular use, intravenous use
Slovenian: MIACALCIC 100 NE/ml oldatos injekció és infúzió raztopina za injiciranje/infundiranje subkutana uporaba, intramuskularna uporaba, intravenska uporaba
English: OSPOR 200 UI solución para pulverización nasal 200 IU
Slovenian: OSPOR 200 UI solución para pulverización nasal
English: Osteos 100 I.E./ml solution for injection intravenous use, intramuscular use, subcutaneous use
Slovenian: Osteos 100 I.E./ml raztopina za injiciranje intravenska uporaba, intramuskularna uporaba, subkutana uporaba
English: Calcitonin-ratiopharm 50 I.E. Ampullen solution for injection intravenous use, intramuscular use, subcutaneous use
Slovenian: Calcitonin-ratiopharm 50 I.E. Ampullen raztopina za injiciranje intravenska uporaba, intramuskularna uporaba, subkutana uporaba
English: Calcitonin-CT 50 I.E./ml Ampullen solution for injection intravenous use, intramuscular use, subcutaneous use
Slovenian: Calcitonin-CT 50 I.E./ml Ampullen raztopina za injiciranje intravenska uporaba, intramuskularna uporaba, subkutana uporaba
English: Calcitonin-CT 100 I.E./ml Ampullen solution for injection intravenous use, intramuscular use, subcutaneous use
Slovenian: Calcitonin-CT 100 I.E./ml Ampullen raztopina za injiciranje intravenska uporaba, intramuskularna uporaba, subkutana uporaba
English: Osteos 50 I.E./ml solution for injection intravenous use, intramuscular use, subcutaneous use
Slovenian: Osteos 50 I.E./ml raztopina za injiciranje intravenska uporaba, intramuskularna uporaba, subkutana uporaba
English: Miacalcic 50 IU/1 ml solution for injection, concentrate for solution for infusion subcutaneous use, intramuscular use, intravenous use
Slovenian: Miacalcic 50 IU/1 ml raztopina za injiciranje, koncentrat za raztopino za infundiranje subkutana uporaba, intramuskularna uporaba, intravenska uporaba
English: CALCITONINA SANDOZ 50 UI/ml solution for injection and infusion intravenous use, intramuscular use, subcutaneous use
Slovenian: CALCITONINA SANDOZ 50 i.e./ml raztopina za injiciranje in infundiranje intravenska uporaba, intramuskularna uporaba, subkutana uporaba
English: Novartis Pharma B.V. Raapopseweg 1
Slovenian: Novartis Pharma B.V.
English: solution for injection/infusion intravenous use, intramuscular use, subcutaneous use
Slovenian: raztopina za injiciranje/infundiranje intravenska uporaba, intramuskularna uporaba, subkutana uporaba
English: Calcitonine Cédiat solution for injection intramuscular use, intravenous use, subcutaneous use
Slovenian: Calcitonine Cédiat raztopina za injiciranje intramuskularna uporaba, intravenska uporaba, subkutana uporaba
English: Miacalcic 50 IU/ml Ampoules solution for injection subcutaneous use, intramuscular use, intravenous use
Slovenian: Miacalcic 50 IU/ml Ampoules raztopina za injiciranje subkutana uporaba, intramuskularna uporaba, intravenska uporaba
English: solution for injection subcutaneous use, intramuscular use, intravenous use
Slovenian: raztopina za injiciranje subkutana uporaba, intramuskularna uporaba, intravenska uporaba
English: Miacalcic 100 IU/1 ml solution for injection, concentrate for solution for infusion subcutaneous use, intramuscular use, intravenous use
Slovenian: Miacalcic 100 IU/1 ml raztopina za injiciranje, koncentrat za raztopino za infundiranje subkutana uporaba, intramuskularna uporaba, intravenska uporaba
English: Calcitonin 100 Jelfa
Slovenian: Calcitonin 100 Jelfa injekcija subkutana uporaba